Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia/reperfusion

Journal of Molecular Neuroscience

Volumn 36, Issue 1-3, 2008, Pages 89-96

  Szakaly, Peter ^a   Kiss, Peter ^a   Lubics, Andrea ^a   Magyarlaki, Tamas ^b   Tamas, Andrea ^a   Racz, Boglarka ^a   Lengvari, Istvan ^a   Toth, Gabor ^c   Reglodi, Dora ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Ischemia; Kidney; Renoprotection; Tubular atrophy

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; KIDNEY ARTERY; KIDNEY DYSFUNCTION; KIDNEY ISCHEMIA; KIDNEY STRUCTURE; NONHUMAN; RAT; RENAL PROTECTION; SURVIVAL;

ANIMALS; CELL SURVIVAL; ISCHEMIA; KIDNEY; MALE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; REPERFUSION;

ANIMALIA; RATTUS;

EID: 58149094044     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9064-8     Document Type: Article

References (59)

1. C. Abad R. P. Gomariz J. A. Waschek 2006 Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP Current Topics in Medicinal Chemistry 6 151 163
2. A. Arimura 2007 PACAP: The road to discovery Peptides 28 1617 1619
3. A. Arimura M. Li V. Batuman 2006 Potential protective action of pituitary adenylate cyclase activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury Blood 107 661 668
4. A. Arimura M. Li V. Batuman 2006 Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38 Annals of the New York Academy of Sciences 1070 1 4
5. T. Atlasz N. Babai P. Kiss 2007 Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats General and Comparative Endocrinology 153 108 114
6. W. A. Banks D. Uchida A. Arimura A. Somogyvari-Vigh S. Shioda 1996 Transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons Annals of the New York Academy of Sciences 805 270 277
7. K. M. Braas V. May P. Zwara 2006 Role for pituitary adenylate cyclase activating polypeptide in cystitis-induced plasticity of micturition reflexes American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 290 951 962
8. Danovitch, G. M. (2005). Handbook of kidney transplantation. Lippincott: Williams and Wilkins.
9. M. Delgado D. Ganea 2000 VIP and PACAP inhibit activation induced apoptosis in T lymphocytes Annals of the New York Academy of Sciences 921 55 67
10. +thymocytes from glucocorticoid-induced apoptosis Blood 12 5152 5161
11. J. Fahrenkrug J. Hannibal 1998 Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract Neuroscience 83 1261 1272
12. S. Faubel C. L. Edelstein 2005 Caspases as drug targets in ischemic organ injury. Current Drug Targets-Endocrinology and Metabolism Disorder 5 269 287
13. A. Fekete A. Vannay A. Ver 2006 Sex differences in heat shock protein 72 expression and localization in rats following renal ischemia-reperfusion injury American Journal of Physiology. Renal Physiology 291 806 811
14. S. M. Gardiner T. Rakhit P. A. Kemp J. E. March T. Bennett 1994 Regional haemodynamic responses to pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in conscious rats British Journal of Pharmacology 111 589 597
15. B. Gasz B. Racz E. Roth 2006 Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis Peptides 27 87 94
16. B. Gasz B. Racz E. Roth 2006 PACAP inhibits oxidative stress-induced activation of MAP kinase dependent apoptotic pathway in cultured cardiomyocytes Annals of the New York Academy of Sciences 1070 293 297
17. R. P. Gomariz Y. Juarranz C. Abad A. Arranz J. Leceta C. Martinez 2006 VIP-PACAP system in immunity: New insights for multitarget therapy Annals of the New York Academy of Sciences 1070 51 74
18. I. Gutierrez-Canas N. Rodriguez-Henche O. Bolanos M. J. Carmena J. C. Prieto M. G. Juarranz 2003 VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal British Journal of Pharmacology 139 1050 1058
19. A. J. Harmar W. J. Sheward C. F. Morrison B. Waser M. Gugger J. C. Reubi 2004 Distribution of the VPAC2 receptor in peripheral tissues of the mouse Endocrinology 145 1203 1210
20. M. Hautmann U. G. Friis M. Desch 2007 Pituitary adenylate cyclase activating polypeptide stimulates renin secretion via activation of PAC1 receptors Journal of the American Society of Nephrology 18 1150 1156
21. Zs. Helyes G. Pozsgai R. Borzsei 2007 Inhibitory effect of PACAP38 on acute neurogenic and non-neurogenic inflammation in the rat Peptides 28 1847 1855
22. G. M. Herrera K. M. Braas V. May M. A. Vizzard 2006 PACAP enhances mouse urinary bladder contractility and is upregulated in micturition reflex pathways after cystitis Annals of the New York Academy of Sciences 1070 330 336
23. K. J. Kelly B. A. Molitoris 2000 Acute renal failure in the new millennium: Time to consider combination therapy Seminars in Nephrology 20 4 19
24. H. C. Lam K. Takahashi M. A. Ghatei S. M. Kanse J. M. Polak S. R. Bloom 1990 Binding sites of a novel neuropeptide pituitary adenylate cyclase activating polypeptide in the rat brain and lung European Journal of Biochemistry 193 725 729
25. J. M. Lauffer I. M. Modlin L. H. Tang 1999 Biological relevance of pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract Regulatory Peptides 84 1 12
26. J. Lee H. J. Park H. S. Choi 1999 Gonadotropin stimulation of pituitary adenylate cyclase activating polypeptide (PACAP) messenger ribonucleic acid in the rat ovary and the role of PACAP as a follicle survival factor Endocrinology 140 818 826
27. M. Li S. Cortez T. Nakamachi V. Batuman A. Arimura 2006 Pituitary adenylate cyclase activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells Cancer Research 66 8796 8803
28. M. Li J. L. Maderdrut J. J. Lertora V. Batuman 2007 Intravenous infusion of pituitary adenylate cyclase activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: a case study Peptides 28 1891 1895
29. M. Li J. L. Maderdru J. J. Lertora A. Arimura V. Batuman 2008 Renoprotection by pituitary adenylate cyclase activating polypeptide in multiple myeloma and other kidney diseases Regulatory Peptides 145 24 32
30. M. Li K. S. Hering-Smith E. E. Simon V. Batuman 2008 Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrology Dialysis Transplantation 23 3 860 870
31. A. Miyata A. Arimura R. R. Dahl 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells Biochemical and Biophysical Research Communications 164 567 574
32. J. Nemeth D. Reglodi G. Pozsgai 2006 Effect of PACAP-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice Neuroscience 143 223 230
33. S. F. Nilsson 1994 PACAP-27 and PACAP-38: Vascular effects in the eye and some other tissues in the rabbit European Journal of Pharmacology 253 17 25
34. H. Ohtaki T. Nakamachi K. Dohi 2006 Pituitary adenylate cyclase activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6 Proceedings of the National Academy of Sciences of the United States of America 103 7488 7493
35. H. Oka L. Jin E. Kulig B. W. Scheithauer R. V. Lloyd 1996 Pituitary adenylate cyclase activating polypeptide inhibits transforming growth factor-b1-induced apoptosis in a human pituitary adenoma cell line American Journal of Pathology 155 1893 1900
36. K. Peeters H. H. Gerets K. Princen F. Vandesande 1999 Molecular cloning and expression of a chicken pituitary adenylate cyclase activating polypeptide receptor Molecular Brain Research 71 244 255
37. B. Racz B. Gasz B. Borsiczky 2007 Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis General and Comparative Endocrinology 153 115 123
38. B. Racz F. Gallyas Jr. P. Kiss 2007 Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats Neurotoxicity Research 12 95 104
39. B. Racz B. Gasz F. Gallyas Jr. 2008 PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis Regulatory Peptides 145 105 115
40. D. Reglodi A. Tamas A. Lubics L. Szalontay I. Lengvari 2004 Morphological and functional effects of PACAP in a 6-hydroxydopamine-induced lesion of the substantia nigra in rats Regulatory Peptides 123 85 94
41. D. Reglodi A. Tamas A. Somogyvari-Vigh 2002 Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia Peptides 23 2227 2234
42. J. C. Reubi 2000 In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues. Clinical implications Annals of the New York Academy of Sciences 921 1 25
43. M. Riera J. Torras J. M. Cruzado 2001 The enhancement of endogenous cAMP with pituitary adenylate cyclase activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response Transplantation 72 1217 1223
44. K. Sandgren Z. Lin E. Ekblad 2003 Differential effects of VIP and PACAP on survival of cultured adult rat myenteric neurons Regulatory Peptides 111 211 217
45. S. Shioda H. Ohtaki T. Nakamachi 2006 Pleiotropic functions of PACAP in the CNS. Neuroprotection and neurodevelopment Annals of the New York Academy of Sciences 1070 550 560
46. B. D. Shivers T. J. Gorcs P. E. Gottschall A. Arimura 1991 Two high affinity binding sites for pituitary adenylate cyclase activating polypeptide have different tissue distributions Endocrinology 128 3055 3065
47. A. Somogyvari-Vigh D. Reglodi 2004 Pituitary adenylate cyclase activating polypeptide: A potential neuroprotective peptide-review Current Pharmaceutical Design 10 2861 2889
48. S. P. Sreedharan J. X. Huang M. C. Cheung E. J. Goetzl 1995 Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene Proceedings of the National Academy of Sciences of the United States of America 92 2939 2943
49. A. Tamas A. Zsombok O. Farkas 2006 Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats Journal of Neurotrauma 23 686 695
50. D. Vaudry B. J. Gonzalez M. Basille Y. Anouar A. Fournier H. Vaudry 1998 Pituitary adenylate cyclase activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway Neuroscience 84 801 812
51. D. Vaudry B. J. Gonzalez M. Basille L. Yon A. Fournier H. Vaudry 2000 Pituitary adenylate cyclase activating polypeptide and its receptors: from structure to functions Pharmacological Reviews 52 269 324
52. Vaudry, D., Ravni, A., Wurtz, O., et al. (2006). Effects of PACAP in the local regulation of endocrine glands. In A. J. Kastin (Ed.) Handbook of biologically active peptides (pp. 867-874). London: Academic.
53. M. A. Vizzard 2000 Up-regulation of pituitary adenylate cyclase activating polypeptide in urinary bladder pathways after chronic cystitis Journal of Comparative Neurology 420 335 348
54. M. A. Vizzard 2006 Neurochemical plasticity and the role of neurotrophic factors in bladder reflex pathways after spinal cord injury Progress in Brain Research 152 97 115
55. J. B. Warren L. E. Donnelly S. Cullen 1991 Pituitary adenylate cyclase activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxant European Journal of Pharmacology 197 131 134
56. J. A. Waschek 2002 Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration Developmental Neuroscience 24 14 23
57. Y. Wei S. Mojsov 1996 Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology Journal of Neuroendocrinology 8 811 817
58. P. Zvara K. M. Braas V. May M. A. Vizzard 2006 A role for pituitary adenylate cyclase activating polypeptide (PACAP) in detrusor hyperreflexia after spinal cord injury (SCI) Annals of the New York Academy of Sciences 1070 622 628
59. K. Zvarova J. D. Dunleavy M. A. Vizzard 2005 Changes in pituitary adenylate cyclase activating polypeptide expression in urinary pathways after spinal cord injury Experimental Neurology 192 46 59